Legal

Kalshi CEO Mansour takes to CNBC amid New York lawsuit

Published Aug 3, 2026

Kalshi co-founder and CEO Tarek Mansour appeared on CNBC on August 3, 2026 for a televised interview. The CNBC segment aired on 'Squawk on the Street.' A separate social media post said the topic was a New York state lawsuit against Kalshi. Neither source provided details of Mansour's remarks or the substance of the discussion. The event marks Kalshi's first public response since the New York attorney general filed suit against the company.

Why this matters?

Kalshi's CEO chose a national broadcast to address a state enforcement action, a move that signals the company views public persuasion as part of its legal strategy. New York's lawsuit alleges an illegal gambling operation, and Mansour's appearance on CNBC suggests Kalshi wants to frame the dispute as a federal-versus-state regulatory conflict before a business audience.

That framing matters because traders already face contract voiding risk from contradictory orders: New York demands shutdown while CFTC rules require continued operation. The platform must now manage messaging, litigation, and trading continuity at once. Every other CFTC-registered venue is watching whether broadcast counter-pressure softens state enforcement or backfires in court. Polymarket in particular faces the same New York playbook and will track whether Kalshi's media gambit gains traction with regulators or investors.

In this story
Add Prediction News as a preferred source on GoogleGet our prediction-market coverage prioritized in your search results

Related Stories

More in Legal
Legal

New York attorney general sues Kalshi over alleged illegal gambling operation

Legal

Polymarket to challenge French ISP block as unlicensed gambling site

Legal

Federal judge blocks Minnesota's first-in-the-nation prediction market ban

Legal

Fanatics head of RG likens Kalshi, Polymarket to black market operators

Legal

Judge rejects CFTC bid to stop Wisconsin prediction market crackdown

Opinion

Kalshi and Polymarket draw widening scrutiny over drug, TV, and political betting